COMPASS PATHWAYS PLC Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-02-27: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2024-02-29: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2023-02-28: Form 10-K; Item Well-known seasoned issuer; As filed No.
- 2022-08-04: Form 10-Q; Item Smaller reporting company; As filed No.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-02-27 | 10-K | Well-known seasoned issuer | No |
| 2024-02-29 | 10-K | Well-known seasoned issuer | No |
| 2023-02-28 | 10-K | Well-known seasoned issuer | No |
| 2022-08-04 | 10-Q | Smaller reporting company | No |
| 2022-05-10 | 10-Q | Smaller reporting company | No |
| 2022-02-24 | 10-K | Smaller reporting company | No |
| 2022-02-24 | 10-K | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |